Related Experiment Video
Updated: Mar 11, 2026
09:52
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
8.1K
First-line therapy for young patients with CLL
1Department of Leukemia, MD Anderson Cancer Center, Houston, TX; and.
Hematology. American Society of Hematology. Education Program
|December 4, 2016
Summary
This patient with chronic lymphocytic leukemia (CLL) presents with symptomatic disease, including fatigue and night sweats, requiring treatment. Prognostic markers suggest a specific disease subtype needing tailored therapy.
Area of Science:
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy.
- Patients may present with symptomatic disease or complications.
- Prognostic factors influence treatment decisions.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K